Skip to main content

Articles

Page 27 of 70

  1. Patients with recurrent retroperitoneal and pelvic region tumors often require multimodal therapies. Intraoperative radiation therapy (IORT) can deliver high-dose radiation to tumor beds, even if first-line ex...

    Authors: Tharcisio Machado Coelho, Ricardo César Fogaroli, Antonio Cassio Assis Pellizzon, Douglas Guedes De Castro, Guilherme Rocha Melo Gondim, Maria Leticia Gobo Silva, Michael Jenwei Chen and Henderson Ramos
    Citation: Radiation Oncology 2018 13:224
  2. Currently, the standard treatment for locally advanced cervical cancer patients is concurrent chemoradiotherapy. Here we aim to evaluate therapeutic efficacy, treatment failure, toxicity and prognostic factors...

    Authors: Qingyu Meng, Weiping Wang, Xiaoliang Liu, Xiaorong Hou, Xin Lian, Shuai Sun, Junfang Yan, Zhikai Liu, Zheng Miao, Ke Hu and Fuquan Zhang
    Citation: Radiation Oncology 2018 13:223
  3. The dosimetric leaf gap (DLG) and multileaf collimator (MLC) transmission are two important systematic parameters used to model the rounded MLC leaf ends effect when commissioning an Eclipse treatment planning...

    Authors: Chih-Yuan Lin, An-Cheng Shiau, Jin-Huei Ji, Chia-Jung Lee, Ti-Hao Wang, Shu-Hui Hsu and Ji-An Liang
    Citation: Radiation Oncology 2018 13:222
  4. It has been reported that proximity of the tumor to the optic disc and macula, and radiation dose to the critical structures are substantial risk factors for vision loss following plaque brachytherapy. However...

    Authors: Yongsook C. Lee, Shih-Chi Lin and Yongbok Kim
    Citation: Radiation Oncology 2018 13:221
  5. Cells in solid tumours are variably hypoxic and hence resistant to radiotherapy - the essential role of oxygen in the efficiency of irradiation has been acknowledged for decades. However, the currently availab...

    Authors: Olli Metsälä, Joose Kreutzer, Heidi Högel, Petra Miikkulainen, Pasi Kallio and Panu M. Jaakkola
    Citation: Radiation Oncology 2018 13:220
  6. To propose an easily applicable segmentation method (perPET-RT) for delineation of tumour volume during radiotherapy on interim fluorine 18 fluorodeoxyglucose (FDG) positron emission tomography/computed tomogr...

    Authors: J. Ganem, S. Thureau, I. Gardin, R. Modzelewski, S. Hapdey and P. Vera
    Citation: Radiation Oncology 2018 13:219
  7. This study was performed to evaluate skin toxicity during modern three-dimensional conformal radiotherapy (3D-CRT) and to evaluate the importance of dose distribution and patient related factors.

    Authors: Kai J. Borm, Maximilian Loos, Markus Oechsner, Michael C. Mayinger, Daniela Paepke, Marion B. Kiechle, Stephanie E. Combs and Marciana N. Duma
    Citation: Radiation Oncology 2018 13:218
  8. A high neutrophil-to-lymphocyte ratio (NLR) is a marker of systemic inflammation and together with the platelet-to-lymphocyte ratio (PLR) is associated with worse outcomes in several solid tumors. We investiga...

    Authors: Beat Bojaxhiu, Arnoud J. Templeton, Olgun Elicin, Mohamed Shelan, Kathrin Zaugg, Marc Walser, Roland Giger, Daniel M. Aebersold and Alan Dal Pra
    Citation: Radiation Oncology 2018 13:216
  9. Cancer cachexia is a prevalent symptom of head and neck neoplasms. The reduction in skeletal muscle mass is one of the main characteristics which can lead to poor physical functioning. The purposes of this pil...

    Authors: Manuel Grote, Cornelius Maihöfer, Martin Weigl, Patricia Davies-Knorr and Claus Belka
    Citation: Radiation Oncology 2018 13:215
  10. Dose escalation of conventionally fractionated radiation therapy (CFRT) above 45–54 Gy has an unclear survival benefit. Prior National Cancer Database (NCDB) analyses have shown improved overall survival with ...

    Authors: Sung Jun Ma, Kavitha M. Prezzano, Gregory M. Hermann and Anurag K. Singh
    Citation: Radiation Oncology 2018 13:214
  11. To determine the prognostic impact of comorbidity and age in medically inoperable early-stage non-small cell lung cancer (NSCLC) treated with stereotactic body radiotherapy (SBRT) using the age-adjusted Charls...

    Authors: Julia Dreyer, Michael Bremer and Christoph Henkenberens
    Citation: Radiation Oncology 2018 13:213
  12. This was a prespecified secondary analysis of a randomized trial that analyzed bone density and pain response following fractionated intensity-modulated radiotherapy (IMRT) versus three-dimensional conformal r...

    Authors: Tanja Sprave, Vivek Verma, Robert Förster, Ingmar Schlampp, Katharina Hees, Thomas Bruckner, Tilman Bostel, Rami Ateyah El Shafie, Thomas Welzel, Nils Henrik Nicolay, Jürgen Debus and Harald Rief
    Citation: Radiation Oncology 2018 13:212
  13. [18F] fluorodeoxyglucose positron emission tomography/computed tomography ([18F] FDG-PET/CT) may be used for tumor staging and prognosis in several tumors but its role in rectal cancer is still debated. The ai...

    Authors: Letizia Deantonio, Angela Caroli, Erinda Puta, Daniela Ferrante, Francesco Apicella, Lucia Turri, Gianmauro Sacchetti, Marco Brambilla and Marco Krengli
    Citation: Radiation Oncology 2018 13:211
  14. HOTAIR was known to enhance radioresistance in several cancers. However, the function of HOTAIR on radioresistance involving the regulation of HIF-1α in cervical cancer has not been reported.

    Authors: Ning Li, Dan-dan Meng, Ling Gao, Yue Xu, Pei-jie Liu, Yong-wei Tian, Zhen-ying Yi, Yan Zhang, Xiao-jing Tie and Zhi-qiao Xu
    Citation: Radiation Oncology 2018 13:210
  15. To evaluate long-term IPSS score and urinary quality of life after radiotherapy for prostate cancer, in patients with prior history of surgical treatment for benign prostatic hyperplasia (BPH).

    Authors: Mélanie Guilhen, Christophe Hennequin, Idir Ouzaid, Ingrid Fumagalli, Valentine Martin, Sophie Guillerm, Pierre Mongiat-Artus, Vincent Ravery, François Desgrandchamps and Laurent Quéro
    Citation: Radiation Oncology 2018 13:209
  16. Concomitant chemo-radiotherapy is the reference treatment for non-resectable locally-advanced Non-Small Cell Lung Cancer (NSCLC). Increasing radiotherapy total dose in the whole tumour volume has been shown to...

    Authors: Sébastien Thureau, Bernard Dubray, Romain Modzelewski, Pierre Bohn, Sébastien Hapdey, Sabine Vincent, Elodie Anger, David Gensanne, Nicolas Pirault, Gouel Pierrick and Pierre Vera
    Citation: Radiation Oncology 2018 13:208
  17. The aim of our study was to evaluate feasibility, toxicity profile and local control of salvage intensity modulated radiotherapy (IMRT) delivered with simultaneous integrated boost (SIB) associated or not to c...

    Authors: L. Nicosia, L. Agolli, C. Reverberi, V. De Sanctis, L. Marinelli, G. Minniti, J. Di Muzio, M. Valeriani and M. F. Osti
    Citation: Radiation Oncology 2018 13:207
  18. Radiotherapy of liver metastases is commonly being performed with photon-beam based stereotactic body radiation therapy (SBRT). The high risk for radiation-induced liver disease (RILD) is a limiting factor in ...

    Authors: Gracinda Mondlane, Ana Ureba, Michael Gubanski, P A Lind and Albert Siegbahn
    Citation: Radiation Oncology 2018 13:206
  19. To assess the efficacy and safety of stereotactic body radiation therapy (SBRT) in the management of adrenal gland metastases (AGMs) from lung cancer. Moreover, it is the first two-institutional experience and...

    Authors: Xianzhi Zhao, Xiaofei Zhu, Jianfeng Fei, Haipeng Ren, Yangsen Cao, Xiaoping Ju, Zhiyong Yuan and Huojun Zhang
    Citation: Radiation Oncology 2018 13:205
  20. Stereotactic ablative radiotherapy (SABR) offers an alternative treatment for pancreatic cancer, with the potential for improved tumour control and reduced toxicity compared with conventional therapies. Howeve...

    Authors: Christy Goldsmith, P. Nicholas Plowman, Melanie M. Green, Roger G. Dale and Patricia M. Price
    Citation: Radiation Oncology 2018 13:204
  21. Computed tomography (CT) data used for patient radiotherapy planning can nowadays be used to create 3D-printed boluses. Nevertheless, this methodology requires a second CT scan and planning process when immobi...

    Authors: Giovanna Dipasquale, Alexis Poirier, Yannick Sprunger, Johannes Wilhelmus Edmond Uiterwijk and Raymond Miralbell
    Citation: Radiation Oncology 2018 13:203
  22. Technological advances in Hodgkin lymphoma (HL) radiation therapy (RT) by high conformal treatments potentially increase control over organs-at-risk (OARs) dose distribution. However, plan optimization remains...

    Authors: Stefania Clemente, Caterina Oliviero, Giuseppe Palma, Vittoria D’Avino, Raffaele Liuzzi, Manuel Conson, Roberto Pacelli and Laura Cella
    Citation: Radiation Oncology 2018 13:202
  23. Radiation-induced heart disease is mainly caused by activation of the fibrotic process. Transforming growth factor-beta 1 (TGF-β1) and platelet-derived growth factor (PDGF) are pro-fibrotic mediators. The aim ...

    Authors: Hanna Aula, Tanja Skyttä, Suvi Tuohinen, Tiina Luukkaala, Mari Hämäläinen, Vesa Virtanen, Pekka Raatikainen, Eeva Moilanen and Pirkko-Liisa Kellokumpu-Lehtinen
    Citation: Radiation Oncology 2018 13:201
  24. The prognostic value of supra-clavicular lymph node (SCLN) metastases in esophageal cancer (EC) is still not clear.

    Authors: Hong-Yao Xu, Sheng-Xi Wu, He-San Luo, Chu-Yun Chen, Lian-Xing Lin and He-Cheng Huang
    Citation: Radiation Oncology 2018 13:200
  25. Two prospective phase II trials were designed to assess the efficacy and safety of image-guided proton therapy (IGPT) for either medically inoperable or operable stage I non-small cell lung cancer (NSCLC). The...

    Authors: Koichiro Nakajima, Hiromitsu Iwata, Hiroyuki Ogino, Yukiko Hattori, Shingo Hashimoto, Toshiyuki Toshito, Kensuke Hayashi, Kenji Akita, Fumiya Baba, Katsumi Nakamae, Jun-etsu Mizoe and Yuta Shibamoto
    Citation: Radiation Oncology 2018 13:199
  26. In adults, a single pre-treatment four-dimensional CT (4D-CT) acquisition is often used to account for respiratory-induced target motion during radiotherapy. However, studies have indicated that a 4D-CT is not...

    Authors: Sophie C. Huijskens, Irma W. E. M. van Dijk, Jorrit Visser, Brian V. Balgobind, Coen R. N. Rasch, Tanja Alderliesten and Arjan Bel
    Citation: Radiation Oncology 2018 13:198
  27. To compare patterns of care for elderly patients versus non-elderly patients with non-surgically treated stage III non-small cell lung cancer (NSCLC) using the National Cancer Database (NCDB). We hypothesize t...

    Authors: Eric D Miller, James L Fisher, Karl E Haglund, John C Grecula, Meng Xu-Welliver, Erin M Bertino, Kai He, Peter G Shields, David P Carbone, Terence M Williams, Gregory A Otterson and Jose G Bazan
    Citation: Radiation Oncology 2018 13:196
  28. Adjuvant radiotherapy in advanced head and neck squamous cell cancer (HNSCC) reduces the risk of local-regional failure and most likely increases the survival rate. Patients at high risk for tumor recurrence m...

    Authors: Christiane Matuschek, Jan Haussmann, Edwin Bölke, Stephan Gripp, Patrick J. Schuler, Bálint Tamaskovics, Peter Arne Gerber, Freddy-Joel Djiepmo-Njanang, Kai Kammers, Christian Plettenberg, Bahar Anooshahr, Klaus Orth and Wilfried Budach
    Citation: Radiation Oncology 2018 13:195
  29. Radiation therapy is the standard radical treatment for nasopharyngeal carcinoma (NPC) but also causes transient as well as long-term complications. Patients who develop severe radiation-induced brainstem inju...

    Authors: Cheng-Yun Yao, Guo-Ren Zhou, Li-Jun Wang, Jian-Hua Xu, Jin-jun Ye, Lan-Fang Zhang, Xia He, Zhen-Zhang Chen and Sheng-Fu Huang
    Citation: Radiation Oncology 2018 13:194
  30. Radiation therapy is an indispensable part of various treatment modalities for breast cancer. Specifically, for non-inflammatory locally advanced breast cancer (LABC) patients, preoperative radiotherapy (pRT) ...

    Authors: Miljana Tanić, Ana Krivokuća, Milena Čavić, Jasmina Mladenović, Vesna Plesinac Karapandžić, Stephan Beck, Siniša Radulović, Snezana Susnjar and Radmila Janković
    Citation: Radiation Oncology 2018 13:193
  31. The SpaceOAR hydrogel is employed to limit rectal radiation dose during prostate radiotherapy. We identified a novel parameter – the product of angle θ and hydrogel volume – to quantify hydrogel placement. Thi...

    Authors: Mark E Hwang, Paul J Black, Carl D Elliston, Brian A Wolthuis, Deborah R Smith, Cheng-Chia Wu, Sven Wenske and Israel Deutsch
    Citation: Radiation Oncology 2018 13:192
  32. Pancreatic ductal adenocarcinoma has dismal prognosis. Most patients receive radiation therapy (RT), which is complicated by respiration induced organ motion in upper abdomen. The purpose of this study is to r...

    Authors: Wensha Yang, Zhaoyang Fan, Zixin Deng, Jianing Pang, Xiaoming Bi, Benedick A Fraass, Howard Sandler, Debiao Li and Richard Tuli
    Citation: Radiation Oncology 2018 13:191
  33. Modern radiotherapy offers the possibility of highly accurate tumor treatment. To benefit from this precision at its best, regular positioning verification is necessary. By the use of image-guided radiotherapy...

    Authors: Katharina Bell, Norbert Licht, Christian Rübe and Yvonne Dzierma
    Citation: Radiation Oncology 2018 13:190
  34. Functional magnetic resonance imaging may provide several quantitative indices strictly related to distinctive tissue signatures with radiobiological relevance, such as tissue cellular density and vascular per...

    Authors: Simona Marzi, Alessia Farneti, Antonello Vidiri, Francesca Di Giuliano, Laura Marucci, Filomena Spasiano, Irene Terrenato and Giuseppe Sanguineti
    Citation: Radiation Oncology 2018 13:189
  35. There is currently no worldwide consensus for the management of hepatocellular carcinoma (HCC) with portal vein tumor thrombus (PVTT). We evaluated the efficacy of stereotactic body radiotherapy (SBRT) as the ...

    Authors: Yongjie Shui, Wei Yu, Xiaoqiu Ren, Yinglu Guo, Jing Xu, Tao Ma, Bicheng Zhang, Jianjun Wu, Qinghai Li, Qiongge Hu, Li Shen, Xueli Bai, Tingbo Liang and Qichun Wei
    Citation: Radiation Oncology 2018 13:188
  36. Despite dosimetric benefits of volumetric modulated arc therapy (VMAT) in breast cancer patients with implant reconstruction receiving regional nodal irradiation (RNI), low dose to the thoracic structures rema...

    Authors: Vishruta A. Dumane, Kitwadee Saksornchai, Ying Zhou, Linda Hong, Simon Powell and Alice Y. Ho
    Citation: Radiation Oncology 2018 13:187
  37. Physicians and physicists are expected to contribute to patient safety and quality improvement (QI) in Radiation Oncology (RO), but prior studies suggest that training for this may be inadequate. RO and medica...

    Authors: Matthew B. Spraker, Matthew J. Nyflot, Kristi R. G. Hendrickson, Stephanie Terezakis, Shannon E. Fogh, Gabrielle M. Kane, Eric C. Ford and Jing Zeng
    Citation: Radiation Oncology 2018 13:186
  38. Prostate cancer (PCA) is the most-prevalent non-skin cancer in men worldwide. Nevertheless, the treatment of oligometastatic, especially lymph-node (ln) recurrent, PCA remains elusive. The aim of our study was...

    Authors: M. Oertel, S. Scobioala, K. Kroeger, A. Baehr, L. Stegger, U. Haverkamp, M. Schäfers and H.-T. Eich
    Citation: Radiation Oncology 2018 13:185
  39. The patterns of nodal relapse in submandibular gland carcinoma (SMGC) patients treated with postoperative radiotherapy (PORT) remain unclear. This study aims to investigate the nodal failure patterns and the u...

    Authors: Cheng-En Hsieh, Li-Yu Lee, Yung-Chih Chou, Kang-Hsing Fan, Ngan-Ming Tsang, Joseph Tung-Chieh Chang, Hung-Ming Wang, Shu-Hang Ng, Chun-Ta Liao, Tzu-Chen Yen, Ku-Hao Fang and Chien-Yu Lin
    Citation: Radiation Oncology 2018 13:184
  40. Following the publication of this article [1], the authors noticed that figures 2, 3, 4 and 5 were in the incorrect order and thus had incorrect captions.

    Authors: Nicole Wiedenmann, Hatice Bunea, Hans C. Rischke, Andrei Bunea, Liette Majerus, Lars Bielak, Alexey Protopopov, Ute Ludwig, Martin Büchert, Christian Stoykow, Nils H. Nicolay, Wolfgang A. Weber, Michael Mix, Philipp T. Meyer, Jürgen Hennig, Michael Bock…
    Citation: Radiation Oncology 2018 13:183

    The original article was published in Radiation Oncology 2018 13:159

  41. Following publication of the original article [1], the authors reported that one of the authors’ names is spelled incorrectly. In this Correction the incorrect and correct author name are shown. The original p...

    Authors: Thomas Zilli, Marta Scorsetti, Daniel Zwahlen, Ciro Franzese, Robert Förster, Niccolò Giaj-Levra, Nikolaos Koutsouvelis, Aurelie Bertaut, Michel Zimmermann, Giuseppe Roberto D’Agostino, Filippo Alongi, Matthias Guckenberger and Raymond Miralbell
    Citation: Radiation Oncology 2018 13:182

    The original article was published in Radiation Oncology 2018 13:166

  42. Concurrent chemoradiotherapy is considered curative intent treatment for patients with non-operative esophageal cancer. Radiation-induced heart damage receives much attention. We performed repeated four-dimens...

    Authors: Xue Wang, Jin-Zhi Wang, Jian-Bin Li, Ying-Jie Zhang, Feng-Xiang Li, Wei Wang, Yan-Luan Guo, Qian Shao, Min Xu, Xi-Jun Liu and Yue Wang
    Citation: Radiation Oncology 2018 13:181
  43. This study evaluated the effect of radiation dose rate in patients with hematolymphoid malignancies undergoing myeloablative conditioning with total body irradiation (TBI), for hematopoietic stem cell transpla...

    Authors: Dong-Yun Kim, Il Han Kim, Sung-Soo Yoon, Hyoung Jin Kang, Hee Young Shin and Hyun-Cheol Kang
    Citation: Radiation Oncology 2018 13:180
  44. We report prospectively captured clinical toxicity and patient reported outcomes in a single institutional cohort of patients treated for prostate cancer with proton beam therapy (PBT). This is the largest rep...

    Authors: Howard J. Lee Jr, Meghan W. Macomber, Matthew B. Spraker, Stephen R. Bowen, Daniel S. Hippe, Angela Fung, Kenneth J. Russell, George E. Laramore, Ramesh Rengan, Jay Liao, Smith Apisarnthanarax and Jing Zeng
    Citation: Radiation Oncology 2018 13:179
  45. A novel remote method for external dosimetric TPS-planned auditing of intensity modulated radiotherapy (IMRT) and volumetric modulated arc therapy (VMAT) for clinical trials using electronic portal imaging dev...

    Authors: Narges Miri, Kimberley Legge, Kim Colyvas, Joerg Lehmann, Philip Vial, Alisha Moore, Monica Harris and Peter B. Greer
    Citation: Radiation Oncology 2018 13:178
  46. To compare the efficacies and toxicities of intensity-modulated radiotherapy (IMRT) with three-dimensional conformal radiotherapy (3D-CRT) or conventional two-dimensional radiotherapy (2D-RT) for definitive tr...

    Authors: Yanzhu Lin, Kai Chen, Zhiyuan Lu, Lei Zhao, Yalan Tao, Yi Ouyang and Xinping Cao
    Citation: Radiation Oncology 2018 13:177
  47. To measure the absorbed dose rate to water and penumbra of a Gamma Knife® (GK) using a polymethyl metacrylate (PMMA) phantom.

    Authors: Jae Pil Chung, Young Min Seong, Tae Yeon Kim, Yona Choi, Tae Hoon Kim, Hyun Joon Choi, Chul Hee Min, Hamza Benmakhlouf, Kook Jin Chun and Hyun-Tai Chung
    Citation: Radiation Oncology 2018 13:176

Annual Journal Metrics

  • 2022 Citation Impact
    3.6 - 2-year Impact Factor
    3.8 - 5-year Impact Factor
    1.370 - SNIP (Source Normalized Impact per Paper)
    1.037 - SJR (SCImago Journal Rank)

    2023 Speed
    16 days submission to first editorial decision for all manuscripts (Median)
    132 days submission to accept (Median)

    2023 Usage 
    1,958,690 downloads
    605 Altmetric mentions